Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes
Authors:
- 26 August 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 65 (12) , 1259-1264
Abstract
Montelukast (Singulair) is a selective leukotriene receptor antagonist (LTRA) indicated for the maintenance treatment of asthma. Currently, there are limited prospective, comparative studies in the literature examining the safety of montelukast use in pregnancy.Keywords
This publication has 26 references indexed in Scilit:
- Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During PregnancyAmerican Journal of Psychiatry, 2008
- Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001Perspectives on Sexual and Reproductive Health, 2006
- Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomesThorax, 2006
- A Population-Based Case-Control Study on the Effect of Bronchial Asthma During Pregnancy for Congenital Abnormalities of the OffspringJournal of Asthma, 2006
- Pregnancy outcome of asthmatic patients: A population-based studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2005
- Association between bronchial asthma in pregnancy and shorter gestational age in a population-based studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2005
- Asthma controller therapy during pregnancyAmerican Journal of Obstetrics and Gynecology, 2005
- Asthma During PregnancyObstetrics & Gynecology, 2004
- The use of newer asthma and allergy medications during pregnancyAnnals of Allergy, Asthma & Immunology, 2000
- Perinatal outcomes in women with asthma during pregnancyObstetrics & Gynecology, 1998